Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Pressure grows to recall MPs to debate UK vaccine passports proposal

Mon, 02nd Aug 2021 13:00

(Alliance News) - UK Prime Minister Boris Johnson is facing a renewed backlash within his party over the "threat" of domestic vaccine passports, with demands for members of Parliament to be recalled from their holidays to debate the proposal.

Andrew Bridgen, one of 43 Conservative MPs to sign a declaration opposing vaccine passports, said Parliament should be recalled from its summer recess if ministers are "serious" about asking people to show proof of their vaccine status to gain entry to domestic venues and events.

The call means cross-party backing is emerging for the Commons to return before September.

Last week, the Liberal Democrats, said a change rolled out to the NHS app, allowing users to prove they had been double-jabbed to access domestic settings – as well as for international travel – warranted a recall.

Conservative grandee David Lidington, who was de facto deputy prime minister under Theresa May, added his voice to growing numbers in the Tory Party who are concerned about the prospect of vaccine passports, which are being used in some European countries, including Denmark and France.

The former cabinet minister told Times Radio that introducing a "government certificate of approval" to access certain events would set a "dangerous precedent".

Johnson has announced that he intends to change the rules in September so that only those who are fully vaccinated can attend nightclubs, in a move designed to increase the take-up of vaccination among young people.

According to the Department of Health & Social Care, about two-thirds of people aged 18 to 29 in England have received a first dose.

The nightclub stipulations would be stricter than the coronavirus status certificates used at some mass events in recent months, with clubbers not allowed to use proof of a negative Covid-19 test or evidence of having had the virus to gain entry.

But Johnson was warned by one of his backbenchers that he faced an "embarrassing defeat" if he put the "authoritarian" proposal to a vote in the Commons.

North West Leicestershire MP, Bridgen, told LBC: "I think if the government is serious about the threat of bringing in domestic vaccine passports then, of course, Parliament should be recalled.

"This is a very serious infringement on people's liberties, it is basically unprecedented in this country, and I and a number of colleagues would oppose it."

There are also ethical concerns, with professor of medical ethics Dominic Wilkinson telling the same radio station the idea of using Covid passes as a "stick to punish" those who have not yet opted to get vaccinated was "ethically flawed".

Bridgen suggested the government had looked to change tack in its approach to enticing young people to get jabbed because it knew objections to vaccine passes were growing.

Labour shadow environment secretary, Luke Pollard, said the party was "very cautious" about domestic Covid passports, with leader Keir Starmer ruling out supporting them for use in "everyday life", setting up the possibility of a government defeat on the policy.

Bridgen said: "I personally don't think it would get through the House of Commons in any event and that's why the government has moved on to this carrot inducements for young people."

The so-called "inducements" will see young people offered vouchers and discounts for popular takeaways and taxi rides in exchange for getting a jab.

Uber, Bolt and Deliveroo are among the brands that will be offering incentives to encourage youngsters to get inoculated, DHSC has announced.

Labour MP Pollard, who dubbed the offer "kebabs for jabs", said he doubted the concept "is going to be enough to get that last 30% of young people" vaccinated, and called for youngsters to be given more of a role in leading the campaign to get protected from the virus.

The rumblings over vaccine passports have coincided with a row over travel restrictions, with reports that Chancellor Rishi Sunak has warned Johnson the UK's border policy is "out of step" with international rivals and is hurting the economy.

Sunak, according to the Sunday Times, is said to be calling for Britain to take advantage of its successful vaccination programme by opening up further.

The newspaper quotes a source, who it claims is familiar with the letter, as saying: "Rishi has called time on the travel restrictions."

Shadow transport secretary Jim McMahon said it showed the two most senior figures in government were "in open disagreement" and accused the Tories of being "in chaos over their border policy".

Government data released on Sunday showed that a further 65 people had died in the UK within 28 days of a positive coronavirus test, while a further 24,470 lab-confirmed Covid cases were also recorded.

And more than 85 million Covid-19 vaccines, including first and second doses, have been administered in the UK – with more than 88% of adults having now had a first dose and more 72% getting both doses.

Health Secretary Sajid Javid said: "In under eight months, health services across the UK have delivered more than 85 million doses – this is a phenomenal achievement. It has shown Britain at its best.

"Please get both of your jabs if you haven't already to protect yourself and your loved ones."

Meanwhile, Foreign Secretary Dominic Raab said some of the nine million spare AstraZeneca PLC jabs donated to developing countries last week were "going in arms in Jamaica", with batches also "on their way" to Kenya, Guyana, Belize and Laos.

By Patrick Daly, PA Political Correspondent

source: PA

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.